The Dermatology Institute of Boston
1 clinical trials · Sponsor
◉ Watch The Dermatology Institute of Boston
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis (NCT06461299) | The Dermatology Institute of Boston | 2023-07-17 |
Track The Dermatology Institute of Boston automatically
Every clearance here is in the API, with alerts when new ones post.